Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Increases By 96.0%

Azitra, Inc. (NYSEAMERICAN:AZTR) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 503,000 shares, an increase of 96.0% from the December 31st total of 256,600 shares. Based on an average daily volume of 227,800 shares, the short-interest ratio is currently 2.2 days. Approximately 6.7% of the shares of the company are short sold.

Azitra Price Performance

Azitra stock traded down $0.06 on Wednesday, hitting $0.24. The company’s stock had a trading volume of 2,499,314 shares, compared to its average volume of 4,721,041. Azitra has a one year low of $0.23 and a one year high of $40.80.

Azitra (NYSEAMERICAN:AZTR) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.48) by $0.31. As a group, research analysts anticipate that Azitra will post -2.78 EPS for the current year.

Azitra Company Profile

Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.